Nerve conduction measures in mild diabetic neuropathy in the early diabetes intervention trial: The effects of age, sex, type of diabetes, disease duration, and anthropometric factors

Neurology

Volumn 46, Issue 1, 1996, Pages 85-91

  Albers, James W ^a,c   Brown, Morton B ^a   Sima, Anders A F ^a,b   Greene, Douglas A ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MULTICENTER STUDY; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERONEUS NERVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SURAL NERVE; VIBRATION SENSE;

EID: 0029890139     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.85     Document Type: Article

References (12)

1. American Diabetes Association. Report and recommendations of the San Antonio Conference on diabetic neuropathy. Muscle Nerve 1988;11:661-667.
2. Proceedings of a Consensus Development Conference on Standardized Measures in Diabetic Neuropathy. Neurology 1992; 42:1823-1839.
3. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetes. Muscle Nerve 1988;11:21-32.
4. The DCCT Research Group. Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of the Diabetes Control and Complications Trial (DCCT). Diabetes 1988;37:476-481.
5. A double-blind, placebo-controlled, randomized study of the effects of tolrestat on peripheral nerve morphology and biochemistry in patients with diabetic peripheral sensorimotor neuropathy. Protocol No. 709A-304/306-US. Philadelphia: Wyeth-Ayerst Research, 1991.
6. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-1057.
7. Stetson DS, Albers JW, Silverstein BA, Wolfe RA. Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve 1992;15:1095-1104.
8. Wilbourn AJ. The diabetic neuropathies. In: Brown WF, Bolton CF, eds. Clinical electromyography. Boston: Butterworths, 1987:329-364.
9. Daube JR. Electrophysiologic testing in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D Jr, eds. Diabetic neuropathy. Philadelphia: WB Saunders, 1987:162-176.
10. Britland ST, Young RJ, Sharma AK, Clarke BF. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 1990;39:898-908.
11. Albers JW. Clinical neurophysiology of generalized polyneuropathy. J Clin Neurophysiol 1993;10:149-166.
12. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990;322:1031-1037.